Page 7 - National Jewish Health

Diabetes

Promising vaccine strategy for type 1 diabetes extended to humans

A molecule that prevents Type 1 diabetes in mice has provoked an immune response in human cells, according to researchers at National Jewish Health and the University of Colorado. The findings, published online in the Proceedings ...

Diseases, Conditions, Syndromes

Male smokers at higher risk than females for osteoporosis, fractures

In a large study of middle-aged to elderly smokers, men were more likely than women to have osteoporosis and fractures of their vertebrae. Smoking history and chronic obstructive pulmonary disease (COPD) were independent ...

Immunology

Diabetes drug spurs host defense

Pioglitazone, a medication approved for treatment of type 2 diabetes, can help bypass genetic defects in chronic granulomatous disease to help white blood cells fight bacterial infections, according to researchers at National ...

Sleep disorders

After watching disturbing video, CPAP usage soars

Like more than 20 million other Americans, John Brugger has been diagnosed with sleep apnea. He snored, tossed and turned and struggled to breathe during the night, which often left him not only exhausted the next day but ...

Immunology

Wet wraps cut need for drugs in kids with eczema

The number of children with atopic dermatitis, often referred to as eczema, is on the rise. Some estimate that one in five children in the U.S. now suffers from the painful, itchy skin condition. In an effort to control their ...

Immunology

Researchers learn how beryllium causes deadly lung disease

Using exquisitely detailed maps of molecular shapes and the electrical charges surrounding them, researchers at National Jewish Health have discovered how the metal beryllium triggers a deadly immune response in the lungs. ...

Inflammatory disorders

'Beneficial inflammation' may promote healing in pulmonary fibrosis

Inflammation has long been considered an integral part of the biological process that leads to deadly scarring in idiopathic pulmonary fibrosis. New research at National Jewish Health, however, suggests that a little inflammation ...

Immunology

The nose knows in asthma

It has become increasingly clear in recent years that asthma comes in several variations, with different causes, different pathologies and different responses to therapy. These subtypes of asthma can be identified by knowing ...

Immunology

Bronchial thermoplasty shows long-term effectiveness for asthma

The beneficial effects of bronchial thermoplasty, a non-pharmacologic treatment for asthma, last at least five years, according to researchers at National Jewish Health and other institutions. The therapy, in which heat is ...

Oncology & Cancer

Researchers discover how cancer 'invisibility cloak' works

Researchers at National Jewish Health have discovered how a lipid secreted by cancer tumors prevents the immune system from mounting an immune response against it. When lysophosphatidic acid (LPA) binds to killer T cells, ...

page 7 from 10